Literature DB >> 21131425

Chemokine receptor Ccr2 is critical for monocyte accumulation and survival in West Nile virus encephalitis.

Jean K Lim1, Christopher J Obara, Aymeric Rivollier, Alexander G Pletnev, Brian L Kelsall, Philip M Murphy.   

Abstract

West Nile virus (WNV) is a re-emerging pathogen responsible for outbreaks of fatal meningoencephalitis in humans. Previous studies have suggested a protective role for monocytes in a mouse model of WNV infection, but the molecular mechanisms have remained unclear. In this study, we show that genetic deficiency in Ccr2, a chemokine receptor on Ly6c(hi) inflammatory monocytes and other leukocyte subtypes, markedly increases mortality due to WNV encephalitis in C57BL/6 mice; this was associated with a large and selective reduction of Ly6c(hi) monocyte accumulation in the brain. WNV infection in Ccr2(+/+) mice induced a strong and highly selective monocytosis in peripheral blood that was absent in Ccr2(-/-) mice, which in contrast showed sustained monocytopenia. When a 1:1 mixture of Ccr2(+/+) and Ccr2(-/-) donor monocytes was transferred by vein into WNV-infected Ccr2(-/-) recipient mice, monocyte accumulation in the CNS was not skewed toward either component of the mixture, indicating that Ccr2 is not required for trafficking of monocytes from blood to brain. We conclude that Ccr2 mediates highly selective peripheral blood monocytosis during WNV infection of mice and that this is critical for accumulation of monocytes in the brain.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21131425      PMCID: PMC3402345          DOI: 10.4049/jimmunol.1003003

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  38 in total

1.  Activated microglia mediate neuronal cell injury via a nitric oxide mechanism.

Authors:  C C Chao; S Hu; T W Molitor; E G Shaskan; P K Peterson
Journal:  J Immunol       Date:  1992-10-15       Impact factor: 5.422

Review 2.  CCR5: no longer a "good for nothing" gene--chemokine control of West Nile virus infection.

Authors:  Jean K Lim; William G Glass; David H McDermott; Philip M Murphy
Journal:  Trends Immunol       Date:  2006-06-05       Impact factor: 16.687

3.  Chemokine receptor 2 serves an early and essential role in resistance to Mycobacterium tuberculosis.

Authors:  W Peters; H M Scott; H F Chambers; J L Flynn; I F Charo; J D Ernst
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-03       Impact factor: 11.205

Review 4.  Inflammation and axonal regeneration.

Authors:  P M Richardson; X Lu
Journal:  J Neurol       Date:  1994-12       Impact factor: 4.849

5.  Mycobacterium tuberculosis in chemokine receptor 2-deficient mice: influence of dose on disease progression.

Authors:  Holly M Scott; JoAnne L Flynn
Journal:  Infect Immun       Date:  2002-11       Impact factor: 3.441

6.  CD8+ T cells require perforin to clear West Nile virus from infected neurons.

Authors:  Bimmi Shrestha; Melanie A Samuel; Michael S Diamond
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

Review 7.  West Nile virus: epidemiology and clinical features of an emerging epidemic in the United States.

Authors:  Edward B Hayes; Duane J Gubler
Journal:  Annu Rev Med       Date:  2006       Impact factor: 13.739

Review 8.  The neuropathology of West Nile virus meningoencephalitis. A report of two cases and review of the literature.

Authors:  Todd W Kelley; Richard A Prayson; Angela I Ruiz; Carlos M Isada; Steven M Gordon
Journal:  Am J Clin Pathol       Date:  2003-05       Impact factor: 2.493

9.  Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2.

Authors:  Natalya V Serbina; Eric G Pamer
Journal:  Nat Immunol       Date:  2006-02-05       Impact factor: 25.606

10.  Ly6c+ "inflammatory monocytes" are microglial precursors recruited in a pathogenic manner in West Nile virus encephalitis.

Authors:  Daniel R Getts; Rachael L Terry; Meghann Teague Getts; Marcus Müller; Sabita Rana; Bimmi Shrestha; Jane Radford; Nico Van Rooijen; Iain L Campbell; Nicholas J C King
Journal:  J Exp Med       Date:  2008-09-08       Impact factor: 14.307

View more
  96 in total

Review 1.  The role of chemokines in the pathogenesis of neurotropic flaviviruses.

Authors:  Susana V Bardina; Jean K Lim
Journal:  Immunol Res       Date:  2012-12       Impact factor: 2.829

Review 2.  The contribution of rodent models to the pathological assessment of flaviviral infections of the central nervous system.

Authors:  David C Clark; Aaron C Brault; Elizabeth Hunsperger
Journal:  Arch Virol       Date:  2012-05-17       Impact factor: 2.574

3.  Genotypic and phenotypic characterization of West Nile virus NS5 methyltransferase mutants.

Authors:  Jaclyn A Kaiser; Huanle Luo; Steven G Widen; Thomas G Wood; Claire Y-H Huang; Tian Wang; Alan D T Barrett
Journal:  Vaccine       Date:  2019-10-11       Impact factor: 3.641

Review 4.  Innate host responses to West Nile virus: Implications for central nervous system immunopathology.

Authors:  Giada Rossini; Maria Paola Landini; Francesco Gelsomino; Vittorio Sambri; Stefania Varani
Journal:  World J Virol       Date:  2013-05-12

5.  Cellular factors promoting resistance to effective treatment of glioma with oncolytic myxoma virus.

Authors:  Franz J Zemp; Brienne A McKenzie; Xueqing Lun; Karlyne M Reilly; Grant McFadden; V Wee Yong; Peter A Forsyth
Journal:  Cancer Res       Date:  2014-10-21       Impact factor: 12.701

Review 6.  Risk factors for West Nile virus infection and disease in populations and individuals.

Authors:  Ruth R Montgomery; Kristy O Murray
Journal:  Expert Rev Anti Infect Ther       Date:  2015-01-30       Impact factor: 5.091

Review 7.  West Nile Virus: biology, transmission, and human infection.

Authors:  Tonya M Colpitts; Michael J Conway; Ruth R Montgomery; Erol Fikrig
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

8.  The protective effects of T cell deficiency against brain injury are ischemic model-dependent in rats.

Authors:  Xiaoxing Xiong; Lijuan Gu; Hongfei Zhang; Baohui Xu; Shengmei Zhu; Heng Zhao
Journal:  Neurochem Int       Date:  2012-12-08       Impact factor: 3.921

9.  Cytomegalovirus impairs antiviral CD8+ T cell immunity by recruiting inflammatory monocytes.

Authors:  Lisa P Daley-Bauer; Grace M Wynn; Edward S Mocarski
Journal:  Immunity       Date:  2012-07-27       Impact factor: 31.745

10.  Hematopoietic and nonhematopoietic cells promote Type I interferon- and TLR7-dependent monocytosis during low-dose LCMV infection.

Authors:  Matthew B Buechler; Griffin M Gessay; Shivani Srivastava; Daniel J Campbell; Jessica A Hamerman
Journal:  Eur J Immunol       Date:  2015-09-14       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.